Abstract Details
|
Gustavo Dalto Barroso Machado, MD, MS
PRESENTER |
Dr. Barroso Machado has nothing to disclose. |
| Alexis Schnitzler | Ms. Schnitzler has nothing to disclose. |
| Aaron Fleischer | Mr. Fleischer has nothing to disclose. |
| Sarah Beamish, MS | Ms. Beamish has nothing to disclose. |
| Karyn Frick, PhD | Dr. Frick has received personal compensation for serving as an employee of Estrigenix Therapeutics, Inc.. Dr. Frick has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for eNeuro. Dr. Frick has stock in Estrigenix Therapeutics, Inc.. The institution of Dr. Frick has received research support from National Institutes of Health. The institution of Dr. Frick has received research support from Alzheimer's Association. The institution of Dr. Frick has received research support from UWM Research Foundation. Dr. Frick has received intellectual property interests from a discovery or technology relating to health care. |